vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与MID PENN BANCORP INC（MPB）财务数据对比。点击上方公司名可切换其他公司
MID PENN BANCORP INC的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.3倍（$62.0M vs $47.7M），MID PENN BANCORP INC净利率更高（31.4% vs -4.8%，领先36.1%），MID PENN BANCORP INC同比增速更快（30.8% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $71.8M），过去两年MID PENN BANCORP INC的营收复合增速更高（21.1% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
IRWD vs MPB — 直观对比
营收规模更大
MPB
是对方的1.3倍
$47.7M
营收增速更快
MPB
高出78.1%
-47.3%
净利率更高
MPB
高出36.1%
-4.8%
自由现金流更多
IRWD
多$2.8M
$71.8M
两年增速更快
MPB
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $62.0M |
| 净利润 | $-2.3M | $19.4M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | 43.6% |
| 净利率 | -4.8% | 31.4% |
| 营收同比 | -47.3% | 30.8% |
| 净利润同比 | -200.9% | 47.0% |
| 每股收益（稀释后） | $0.01 | $0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDMPB
| Q4 25 | $47.7M | $62.0M | ||
| Q3 25 | $122.1M | $61.8M | ||
| Q2 25 | $85.2M | $54.3M | ||
| Q1 25 | $41.1M | $47.7M | ||
| Q4 24 | $90.5M | $47.4M | ||
| Q3 24 | $91.6M | $45.3M | ||
| Q2 24 | $94.4M | $44.1M | ||
| Q1 24 | $74.9M | $42.3M |
净利润IRWDMPB
| Q4 25 | $-2.3M | $19.4M | ||
| Q3 25 | $40.1M | $18.3M | ||
| Q2 25 | $23.6M | $4.8M | ||
| Q1 25 | $-37.4M | $13.7M | ||
| Q4 24 | $2.3M | $13.2M | ||
| Q3 24 | $3.6M | $12.3M | ||
| Q2 24 | $-860.0K | $11.8M | ||
| Q1 24 | $-4.2M | $12.1M |
营业利润率IRWDMPB
| Q4 25 | 14.3% | 43.6% | ||
| Q3 25 | 61.8% | 39.3% | ||
| Q2 25 | 53.2% | 7.9% | ||
| Q1 25 | -70.7% | 35.2% | ||
| Q4 24 | 34.8% | 34.1% | ||
| Q3 24 | 28.0% | 32.8% | ||
| Q2 24 | 26.5% | 32.4% | ||
| Q1 24 | 14.7% | 34.8% |
净利率IRWDMPB
| Q4 25 | -4.8% | 31.4% | ||
| Q3 25 | 32.8% | 29.6% | ||
| Q2 25 | 27.7% | 8.8% | ||
| Q1 25 | -90.9% | 28.8% | ||
| Q4 24 | 2.5% | 27.9% | ||
| Q3 24 | 4.0% | 27.1% | ||
| Q2 24 | -0.9% | 26.7% | ||
| Q1 24 | -5.6% | 28.7% |
每股收益（稀释后）IRWDMPB
| Q4 25 | $0.01 | $0.83 | ||
| Q3 25 | $0.23 | $0.79 | ||
| Q2 25 | $0.14 | $0.22 | ||
| Q1 25 | $-0.23 | $0.71 | ||
| Q4 24 | $0.03 | $0.72 | ||
| Q3 24 | $0.02 | $0.74 | ||
| Q2 24 | $-0.01 | $0.71 | ||
| Q1 24 | $-0.03 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-261.8M | $814.1M |
| 总资产 | $396.9M | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRWDMPB
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
总债务IRWDMPB
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
股东权益IRWDMPB
| Q4 25 | $-261.8M | $814.1M | ||
| Q3 25 | $-264.2M | $796.3M | ||
| Q2 25 | $-308.2M | $775.7M | ||
| Q1 25 | $-334.1M | $667.9M | ||
| Q4 24 | $-301.3M | $655.0M | ||
| Q3 24 | $-311.3M | $573.1M | ||
| Q2 24 | $-321.7M | $559.7M | ||
| Q1 24 | $-330.5M | $551.0M |
总资产IRWDMPB
| Q4 25 | $396.9M | $6.1B | ||
| Q3 25 | $396.1M | $6.3B | ||
| Q2 25 | $342.9M | $6.4B | ||
| Q1 25 | $327.2M | $5.5B | ||
| Q4 24 | $350.9M | $5.5B | ||
| Q3 24 | $389.5M | $5.5B | ||
| Q2 24 | $395.6M | $5.4B | ||
| Q1 24 | $438.8M | $5.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $80.0M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $71.8M |
| 自由现金流率自由现金流/营收 | 156.3% | 115.8% |
| 资本支出强度资本支出/营收 | 0.0% | 13.3% |
| 现金转化率经营现金流/净利润 | — | 4.12× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $132.1M |
8季度趋势，按日历期对齐
经营现金流IRWDMPB
| Q4 25 | $74.6M | $80.0M | ||
| Q3 25 | $47.6M | $26.3M | ||
| Q2 25 | $-15.1M | $29.0M | ||
| Q1 25 | $20.0M | $11.5M | ||
| Q4 24 | $15.2M | $51.4M | ||
| Q3 24 | $9.9M | $16.9M | ||
| Q2 24 | $33.5M | $18.0M | ||
| Q1 24 | $45.0M | $12.4M |
自由现金流IRWDMPB
| Q4 25 | $74.6M | $71.8M | ||
| Q3 25 | $47.6M | $24.3M | ||
| Q2 25 | $-15.1M | $27.2M | ||
| Q1 25 | $19.9M | $8.8M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | $9.9M | $16.8M | ||
| Q2 24 | $33.4M | $17.7M | ||
| Q1 24 | $44.9M | $12.1M |
自由现金流率IRWDMPB
| Q4 25 | 156.3% | 115.8% | ||
| Q3 25 | 39.0% | 39.4% | ||
| Q2 25 | -17.7% | 50.1% | ||
| Q1 25 | 48.4% | 18.4% | ||
| Q4 24 | — | 93.8% | ||
| Q3 24 | 10.8% | 37.1% | ||
| Q2 24 | 35.4% | 40.2% | ||
| Q1 24 | 60.0% | 28.5% |
资本支出强度IRWDMPB
| Q4 25 | 0.0% | 13.3% | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.1% | 5.7% | ||
| Q4 24 | 0.0% | 14.6% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.7% | ||
| Q1 24 | 0.1% | 0.8% |
现金转化率IRWDMPB
| Q4 25 | — | 4.12× | ||
| Q3 25 | 1.19× | 1.44× | ||
| Q2 25 | -0.64× | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | 6.74× | 3.88× | ||
| Q3 24 | 2.71× | 1.37× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | — | 1.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
